A portfolio of royalty interests in an antibiotic drug. The portfolio comprises royalty rights in Cubicin, an antibiotic in a class of anti-infectives called lipopeptides.
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Cubicin (Royalty rights)‘s full profile, request access.
Request a free trial